Valuation: Getinge AB

Market Cap 64.93B 6.84B 5.93B 5.53B 5.08B 9.59B 651B 9.7B 25.49B 326B 25.71B 25.14B 1,078B P/E 2026 *
21x
P/E 2027 * 18.7x
Enterprise Value 73.49B 7.75B 6.71B 6.25B 5.75B 10.86B 737B 10.98B 28.85B 369B 29.09B 28.45B 1,221B EV / Sales 2026 *
2.09x
EV / Sales 2027 * 1.92x
Free-Float
78.61%
Yield 2026 *
2.18%
Yield 2027 * 2.36%
1 day-0.16%
1 week+3.36%
Current month+1.02%
1 month+18.27%
3 months+30.53%
6 months+14.55%
Current year+9.44%
1 week 21.51
Extreme 21.51
21.85
1 month 18.16
Extreme 18.16
21.85
Current year 16.36
Extreme 16.355
21.85
1 year 16.36
Extreme 16.355
21.85
3 years 14.23
Extreme 14.23
21.85
5 years 14.23
Extreme 14.23
42.95
10 years 7.17
Extreme 7.168
42.95
Manager TitleAgeSince
Chief Executive Officer 54 30/04/2017
Director of Finance/CFO 48 30/03/2024
Compliance Officer 47 30/09/2020
Director TitleAgeSince
Chairman 65 22/04/2019
Chairman 75 -
Director/Board Member 70 31/12/2006
Change 5-day change 1-year change 3-year change Capi.($)
+0.55%+3.36% - - 6.84B
-0.31%+0.96%+34.61%+28.07% 12.73B
+0.25%+0.66%+52.20%+26.58% 6.13B
-2.26%+0.87% - - 5.21B
-0.48%-1.62%-24.01%+39.21% 4.49B
-0.86%-0.51%-21.63%-19.05% 4.08B
-1.35%+5.59%+40.42%-43.78% 1.87B
0.00%+0.85%-11.46%+195.29% 1.78B
-1.75%+3.10%+57.01%-4.04% 1.66B
0.00%+3.91%-29.43%-49.27% 1.28B
Average -0.71%+1.40%+12.22%+21.63% 4.36B
Weighted average by Cap. -0.58%+0.44%+19.89%+23.93%

Financials

2026 *2027 *
Net sales 35.16B 3.71B 3.21B 2.99B 2.75B 5.2B 352B 5.25B 13.8B 176B 13.92B 13.61B 584B 37.08B 3.91B 3.39B 3.16B 2.9B 5.48B 372B 5.54B 14.55B 186B 14.68B 14.36B 616B
Net income 3.09B 325M 282M 263M 242M 456M 30.93B 461M 1.21B 15.48B 1.22B 1.19B 51.25B 3.46B 364M 316M 294M 271M 511M 34.65B 517M 1.36B 17.34B 1.37B 1.34B 57.42B
Net Debt 8.56B 902M 781M 728M 670M 1.26B 85.8B 1.28B 3.36B 42.93B 3.39B 3.31B 142B 6.33B 667M 578M 539M 495M 935M 63.42B 945M 2.48B 31.73B 2.51B 2.45B 105B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,758
Date Price Change
05/08/26 €21.85 +0.55%
04/08/26 €21.73 -0.05%
03/08/26 €21.74 +0.51%
31/07/26 €21.63 +1.17%
30/07/26 €21.38 +1.14%
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
238.40SEK
Average target price
237.90SEK
Spread / Average Target
-0.21%

Quarterly revenue - Rate of surprise